Sponsor

Avexa

Clinical research sponsor

Published trials6

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

6 shown

A Long Term Safety Study of Apricitabine in HIV-infected PatientsNCT00686270 · lead sponsor · 2008-05-01

WITHDRAWN

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV InfectionNCT00612898 · lead sponsor · 2008-02-01

TERMINATED

A Long Term, Safety Study of Apricitabine in HIV-infected SubjectsNCT00367952 · lead sponsor · 2006-08-01

COMPLETED

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or TogetherNCT00352066 · lead sponsor · 2006-07-01

COMPLETED

A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy SubjectsNCT00334659 · lead sponsor · 2006-06-01

COMPLETED

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIVNCT00126880 · lead sponsor · 2005-07-01

COMPLETED

Sponsor roles

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.